TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet-based Diabetes Education and Case Management
Brief Summary: This study is comparing the effectiveness of web-based care management to either telephone-based care management or internet access alone, in patients with poorly controlled diabetes mellitus.


Options:
A: Intervention Type: PROCEDURE; Name: management of therapy complications; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: pain therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A
B: Arm Label: Arm 1: PE via telemedicine; Type: EXPERIMENTAL; Interventions: Behavioral: Telemedicine | Arm Label: Arm 2: PE in person; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: In Person | Intervention Type: BEHAVIORAL; Name: Telemedicine; Assigned to Arm(s): Arm 1: PE via telemedicine | Intervention Type: BEHAVIORAL; Name: In Person; Assigned to Arm(s): Arm 2: PE in person
C: Arm Label: Forecast; Type: EXPERIMENTAL; Interventions: Behavioral: COPD self care advice, Behavioral: Poor weather forecast warning | Arm Label: No Forecast; Type: EXPERIMENTAL; Interventions: Behavioral: COPD self care advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: COPD self care advice; Assigned to Arm(s): Forecast, No Forecast | Intervention Type: BEHAVIORAL; Name: Poor weather forecast warning; Assigned to Arm(s): Forecast
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Procedure: Web-based care management | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Telephone and face-to-face care management | Arm Label: Arm 3; Type: SHAM_COMPARATOR; Interventions: Procedure: Internet access alone | Intervention Type: PROCEDURE; Name: Web-based care management; Assigned to Arm(s): Arm 1 | Intervention Type: PROCEDURE; Name: Telephone and face-to-face care management; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Internet access alone; Assigned to Arm(s): Arm 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet-based Diabetes Education and Case Management
Brief Summary: This study is comparing the effectiveness of web-based care management to either telephone-based care management or internet access alone, in patients with poorly controlled diabetes mellitus.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Procedure: Web-based care management | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Telephone and face-to-face care management | Arm Label: Arm 3; Type: SHAM_COMPARATOR; Interventions: Procedure: Internet access alone | Intervention Type: PROCEDURE; Name: Web-based care management; Assigned to Arm(s): Arm 1 | Intervention Type: PROCEDURE; Name: Telephone and face-to-face care management; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Internet access alone; Assigned to Arm(s): Arm 3
B: Arm Label: Active Control Group (ACG); Type: OTHER; Interventions: Device: Accu-Chek Aviva Glucose Meter | Arm Label: Structured Testing Group (STG); Type: EXPERIMENTAL; Interventions: Device: Accu-Chek 360° View Blood Glucose Analysis Tool, Device: Accu-Chek Aviva Glucose Meter | Intervention Type: DEVICE; Name: Accu-Chek 360° View Blood Glucose Analysis Tool; Assigned to Arm(s): Structured Testing Group (STG) | Intervention Type: DEVICE; Name: Accu-Chek Aviva Glucose Meter; Assigned to Arm(s): Active Control Group (ACG), Structured Testing Group (STG)
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Dialogue to Educate and Activate (IDEA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual Education (IE) | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interactive Dialogue to Educate and Activate (IDEA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Individual Education (IE); Assigned to Arm(s): 2
D: Arm Label: dashboard team care intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Dashboard Intervention | Arm Label: usual diabetes team control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Diabetes Care | Intervention Type: BEHAVIORAL; Name: Diabetes Dashboard Intervention; Assigned to Arm(s): dashboard team care intervention | Intervention Type: BEHAVIORAL; Name: Usual Diabetes Care; Assigned to Arm(s): usual diabetes team control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
Brief Summary: The purpose of this study is to assess the efficacy and safety of duloxetine compared with placebo in the prevention of depressive recurrences among patients with recurrent major depressive disorder.


Options:
A: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Risperidone, Drug: Escitalopram, Drug: Citalopram, Drug: Sertraline, Drug: Paroxetine | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Paroxetine; Assigned to Arm(s): A
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
C: Arm Label: Supported Protocolized Discontinuation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supported Protocolized Discontinuation (SPD) | Arm Label: SPD + Mindfulness (MBCT); Type: EXPERIMENTAL; Interventions: Behavioral: Supported Protocolized Discontinuation (SPD), Behavioral: Mindfulness Based Cognitive Therapy (MBCT) | Intervention Type: BEHAVIORAL; Name: Supported Protocolized Discontinuation (SPD); Assigned to Arm(s): SPD + Mindfulness (MBCT), Supported Protocolized Discontinuation | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Cognitive Therapy (MBCT); Assigned to Arm(s): SPD + Mindfulness (MBCT)
D: Arm Label: Open-Label Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Drug Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Double-Blind Drug-After-Drug Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Placebo-After-Drug Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Double-Blind Placebo-After-Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Venlafaxine XR; Assigned to Arm(s): Double-Blind Drug Group, Double-Blind Drug-After-Drug Group, Open-Label Group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Double-Blind Placebo Group, Double-Blind Placebo-After-Drug Group, Double-Blind Placebo-After-Placebo Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving the Quality of End-of-Life Communication for Patients With COPD
Brief Summary: The purpose of this study is to evaluate a multifaceted intervention to improve the quality of end-of-life communication between patients with COPD and their primary care providers using information about patients preferences for end of life care and how to communicate and use this information to activate patients, family members, and healthcare providers.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral: The PARTNER II Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PARTNER II | Intervention Type: BEHAVIORAL; Name: PARTNER II; Assigned to Arm(s): Behavioral: The PARTNER II Intervention
B: Arm Label: ICU Usual Care Control; Type: ACTIVE_COMPARATOR; Interventions: Other: ICU Usual Care Control | Arm Label: The PARTNER Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The PARTNER Intervention | Intervention Type: BEHAVIORAL; Name: The PARTNER Intervention; Assigned to Arm(s): The PARTNER Intervention | Intervention Type: OTHER; Name: ICU Usual Care Control; Assigned to Arm(s): ICU Usual Care Control
C: Arm Label: Booklet-Question List (BQL) group; Type: N/A; Interventions: Other: Booklet-Question List | Arm Label: control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: Booklet-Question List; Assigned to Arm(s): Booklet-Question List (BQL) group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Audit and Feedback | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Audit and Feedback; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Detection, Intervention, and Neurobiology in Autism: Early Intervention Portion
Brief Summary: This study will determine the impact of early intervention on the communication and social development of toddlers with autism.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Social skills training targeting children with autism | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Social skills training of peers without autism | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Combination treatment of social skills/education about autism | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual training | Intervention Type: BEHAVIORAL; Name: Social skills training targeting children with autism; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Social skills training of peers without autism; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Combination treatment of social skills/education about autism; Assigned to Arm(s): 3 | Intervention Type: BEHAVIORAL; Name: Usual training; Assigned to Arm(s): 4
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
D: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Detection, Intervention, and Neurobiology in Autism: Early Intervention Portion
Brief Summary: This study will determine the impact of early intervention on the communication and social development of toddlers with autism.


Options:
A: Arm Label: P.L.A.Y. Project Intervention for Autism; Type: EXPERIMENTAL; Interventions: Behavioral: PLAY Project Intervention for Autism | Arm Label: Special Education Pre-school; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Special education pre-school | Intervention Type: BEHAVIORAL; Name: PLAY Project Intervention for Autism; Assigned to Arm(s): P.L.A.Y. Project Intervention for Autism | Intervention Type: BEHAVIORAL; Name: Special education pre-school; Assigned to Arm(s): Special Education Pre-school
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2
C: Arm Label: JAE-EMT; Type: EXPERIMENTAL; Interventions: Behavioral: JAE Intervention | Arm Label: JAE-AAC; Type: EXPERIMENTAL; Interventions: Behavioral: JAE Intervention | Intervention Type: BEHAVIORAL; Name: JAE Intervention; Assigned to Arm(s): JAE-AAC, JAE-EMT
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Detection, Intervention, and Neurobiology in Autism: Early Intervention Portion
Brief Summary: This study will determine the impact of early intervention on the communication and social development of toddlers with autism.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
B: Intervention Type: BEHAVIORAL; Name: Caregiver joint attention intervention; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Functioning in Peripheral Arterial Disease
Brief Summary: The purpose of this study is to compare the effects of nutrition, a supervised treadmill exercise program, and supervised progressive resistance training program on peripheral arterial disease.


Options:
A: Intervention Type: PROCEDURE; Name: Exercise therapy; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Accelerometer (PAM; Personal Activity Monitor); Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Oral Exercise Therapy advise; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Diet | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Diet; Assigned to Arm(s): 3
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Group mediated cognitive behavioral (GMCB) sessions | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Health education sessions | Intervention Type: BEHAVIORAL; Name: Group mediated cognitive behavioral (GMCB) sessions; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Health education sessions; Assigned to Arm(s): 2
D: Arm Label: Strength training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Strength Training | Arm Label: Walking training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Walking Training | Intervention Type: BEHAVIORAL; Name: Walking Training; Assigned to Arm(s): Walking training | Intervention Type: BEHAVIORAL; Name: Strength Training; Assigned to Arm(s): Strength training

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Functioning in Peripheral Arterial Disease
Brief Summary: The purpose of this study is to compare the effects of nutrition, a supervised treadmill exercise program, and supervised progressive resistance training program on peripheral arterial disease.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Group mediated cognitive behavioral (GMCB) sessions | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Health education sessions | Intervention Type: BEHAVIORAL; Name: Group mediated cognitive behavioral (GMCB) sessions; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Health education sessions; Assigned to Arm(s): 2
B: Arm Label: Best medical treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Supervised exercise training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised exercise training | Intervention Type: BEHAVIORAL; Name: Supervised exercise training; Assigned to Arm(s): Supervised exercise training
C: Arm Label: Angioplasty / surgery and exercise therapy; Type: EXPERIMENTAL; Interventions: Procedure: Angioplasty / surgery and exercise therapy | Arm Label: Angioplasty / surgery; Type: NO_INTERVENTION; Interventions: Procedure: angioplasty / surgery | Intervention Type: PROCEDURE; Name: angioplasty / surgery; Assigned to Arm(s): Angioplasty / surgery | Intervention Type: PROCEDURE; Name: Angioplasty / surgery and exercise therapy; Assigned to Arm(s): Angioplasty / surgery and exercise therapy
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Diet | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Diet; Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind Study of GT267-004 Versus Vancomycin, and GT267-004 Versus Metronidazole, in Patients With C.Difficile - Associated Diarrhea
Brief Summary: Approximately 520 patients will be entered into this study taking place throughout the US and Canada. This study aims to determine if an investigational drug is safe and effective for treating symptoms of C. difficile-associated diarrhea (CDAD) and lowering the risk of repeat episodes of CDAD. The investigational drug will be evaluated in comparison to current standard antibiotic treatment, so all patients will receive active medication. All study related care is provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation is approximately 6 weeks.


Options:
A: Arm Label: LFF571 (POC); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: Vancomycin (POC); Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin (POC) | Arm Label: LFF571 Dose level 1 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: LFF571 Dose level 2 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: LFF571 Dose level 3 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: LFF571 Dose level 4 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Intervention Type: DRUG; Name: LFF571; Assigned to Arm(s): LFF571 (POC), LFF571 Dose level 1 (cohort 2), LFF571 Dose level 2 (cohort 2), LFF571 Dose level 3 (cohort 2), LFF571 Dose level 4 (cohort 2) | Intervention Type: DRUG; Name: Vancomycin (POC); Assigned to Arm(s): Vancomycin (POC)
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: PAR-101/OPT-80 | Intervention Type: DRUG; Name: PAR-101/OPT-80; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): 1
C: Arm Label: GS-CDA1/MDX-1388; Type: EXPERIMENTAL; Interventions: Biological: GS-CDA1/MDX-1388 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: normal saline | Intervention Type: BIOLOGICAL; Name: GS-CDA1/MDX-1388; Assigned to Arm(s): GS-CDA1/MDX-1388 | Intervention Type: BIOLOGICAL; Name: normal saline; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: tolevamer potassium-sodium (GT267-004); Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to Anti-TNF Therapy
Brief Summary: This 3 arm study will compare the safety and efficacy, with regard to reduction of signs and symptoms, of tocilizumab versus placebo in combination with methotrexate (MTX) in patients with moderate to severe active rheumatoid arthritis (RA) currently on MTX therapy, and who have had an inadequate response to prior therapy with an anti-tumor necrosis factor (anti-TNF) agent. Patients will be randomized to receive tocilizumab 4mg/kg iv, tocilizumab 8mg/kg or placebo iv, every 4 weeks. All patients will also receive methotrexate 10-25mg/week. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: rituximab [MabThera/Rituxan] | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: rituximab [MabThera/Rituxan] | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: rituximab [MabThera/Rituxan] | Intervention Type: DRUG; Name: rituximab [MabThera/Rituxan]; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: rituximab [MabThera/Rituxan]; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: rituximab [MabThera/Rituxan]; Assigned to Arm(s): 3
B: Arm Label: Tocilizumab + Methotrexate; Type: EXPERIMENTAL; Interventions: Drug: tocilizumab [RoActemra/Actemra], Drug: methotrexate | Arm Label: Tocilizumab + Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: tocilizumab [RoActemra/Actemra], Drug: placebo | Intervention Type: DRUG; Name: tocilizumab [RoActemra/Actemra]; Assigned to Arm(s): Tocilizumab + Methotrexate, Tocilizumab + Placebo | Intervention Type: DRUG; Name: methotrexate; Assigned to Arm(s): Tocilizumab + Methotrexate | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Tocilizumab + Placebo
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Methotrexate, Drug: tocilizumab [RoActemra/Actemra] | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Methotrexate, Drug: tocilizumab [RoActemra/Actemra] | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Methotrexate, Drug: Placebo | Intervention Type: DRUG; Name: Methotrexate; Assigned to Arm(s): 1, 2, 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: tocilizumab [RoActemra/Actemra]; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: tocilizumab [RoActemra/Actemra]; Assigned to Arm(s): 1
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: etanercept | Intervention Type: DRUG; Name: etanercept; Assigned to Arm(s): 1

Answer: C